MaxCyte(DE:MYE0)
€1.05+0.06 (+6.06%)
DE:MYE0
MaxCyte financials statements
€1.05
At close:+0.06 (+6.06%)
MaxCyte (MYE0) Income Statement
0 Followers
MaxCyte Income Statement
Last quarter (Q3 2026), MaxCyte's total revenue was $10.15M, an increase of 48.66% from the same quarter last year. In Q3, MaxCyte's net income was $-4.76M. See MaxCyte’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 33.03M | $ 38.63M | $ 41.29M | $ 44.26M | $ 33.89M | |
| $ 26.80M | $ 31.53M | $ 36.55M | $ 39.16M | $ 30.25M | |
| $ 72.09M | $ 82.72M | $ 84.84M | $ 66.52M | $ 48.44M | |
| Depreciation and Amortization | $ 5.14M | $ 4.32M | $ 4.57M | $ 2.70M | $ 1.42M |
| $ -39.49M | $ -36.74M | $ -33.36M | $ -20.75M | $ -16.61M | |
| $ -45.28M | $ -51.20M | $ -48.30M | $ -27.36M | $ -18.19M | |
| $ 655.00K | $ 10.14M | $ 10.38M | $ 3.79M | $ -893.60K | |
| $ -44.63M | $ -41.05M | $ -37.92M | $ -23.57M | $ -19.08M | |
| $ -44.63M | $ -41.05M | $ -37.92M | $ -23.57M | $ -19.08M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.42 | $ -0.39 | $ -0.37 | $ -0.19 | $ -0.22 |
| Diluted EPS | $ -0.42 | $ -0.39 | $ -0.37 | $ -0.19 | $ -0.22 |
| Weighted Average Shares Outstanding | 106.43M | 104.85M | 103.27M | 101.70M | 90.62M |
| Weighted Average Shares Outstanding (Diluted) | 106.43M | 104.85M | 103.27M | 101.70M | 90.62M |
Currency in USD

